<ul><li>Akums Drugs and Pharmaceutical Ltd. has signed a pact with a global pharma company to manufacture and supply selected pharmaceutical formulations in European market.</li><li>Akums group will manufacture and supply multiple SKUs of oral liquid formulation to be marketed in multiple European countries.</li><li>The commercial supply of these products from Akums will commence in 2027.</li><li>The composite value of the agreement is approx. Euro 200 million or Rs 1,760 crores.</li></ul>

Akums Drugs Inks Rs 1,760-Crore Pact To Make, Supply Oral Liquid Formulation To European Countries

Discover more